Dosage of Ribavirin in Patients With Hepatitis C Should Be Based on Renal Function: A Population Pharmacokinetic Analysis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Prediction of Creatinine Clearance from Serum Creatinine
1976 • 15,066 citations
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 • 3,550 citations
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 • 2,374 citations
Screening for renal disease using serum creatinine: who are we missing?
2001 • 265 citations
Reference values for51Cr-EDTA clearance as a measure of glomerular filtration rate
1981 • 240 citations
The clinical pharmacology of ribavirin.
1999 • 220 citations
Population Pharmacokinetic and Pharmacodynamic Analysis of Ribavirin in Patients With Chronic Hepatitis C
2000 • 171 citations
Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection – a pilot study
2001 • 155 citations
Therapy of hepatitis C: Alpha interferon and ribavirin
1997 • 105 citations
Determination of Ribavirin in Serum Using Highly Selective Solid-Phase Extraction and High-Performance Liquid Chromatography
2000 • 56 citations
Hemodialysis clearance of intravenously administered ribavirin
1990 • 35 citations
Treatment of chronic hepatitis C: another therapeutic option
1996 • 5 citations
Cited By (0)
No citing papers found in database